Trials / Completed
CompletedNCT02714621
MR-HIFU for Recurrent Gynaecological Cancer
Magnetic Resonance Guided High Intensity Focused Ultrasound (MRgHIFU): A Feasibility Study for Treating Recurrent Gynaecological Malignancies
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 31 (actual)
- Sponsor
- Institute of Cancer Research, United Kingdom · Academic / Other
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The primary objective of this pilot study is to determine whether or not it is feasible to use MRgHIFU to treat symptomatic (pain, bleeding) recurrent pelvic malignancy with an acceptable safety profile when conventional treatment options are not available. The ultimate goal is to be able not only to offer a viable method of symptom palliation in patients with recurrent pelvic tumours and improve their quality of life; but also to control tumour growth and extend life in a group of relatively young patients with isolated local recurrence.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Magnetic Resonance Image-guided High Intensity Focused Ultrasound (MR-HIFU) |
Timeline
- Start date
- 2016-05-01
- Primary completion
- 2020-03-31
- Completion
- 2020-03-31
- First posted
- 2016-03-21
- Last updated
- 2020-07-15
Locations
1 site across 1 country: United Kingdom
Source: ClinicalTrials.gov record NCT02714621. Inclusion in this directory is not an endorsement.